Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F S Ali

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Zentralblatt Fur Mikrobiologie|January 1, 1986
Microbiological control of ticksF S Ali, A A Abdel-Moneim, T A el-Dahtory, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Biologically Active Benzimidazole Hybrids as Cancer Therapeutics: Recent AdvancesMohamed A S Badawy, Stefan Bräse, Taha F S Ali, et al.
Life Sciences|June 28, 2024
The protective role of two oxindole derivatives is mediated by modulating NLRP3/caspase-1 and PI3K/AKT pathways in a preclinical animal model of hepatic ischemia reperfusion injuryNardeen Eldafashi, Shaimaa Waaz, Taha F S Ali, et al.
Drug Development Research|May 26, 2026
Discovery of Novel 5-Substituted-4-Allyl-1,2,4-Triazoles as Potential Nonsteroidal Anti-Inflammatory Agents via Downregulation of iNOS ExpressionSamar H Abbas, Asmaa S A Hammad, Dina M M H El-Kossi, et al.
European Journal of Medicinal Chemistry|December 7, 2013
1,2,4-Triazole/oxime hybrids as new strategy for nitric oxide donors: Synthesis, anti-inflammatory, ulceroginicity and antiproliferative activitiesGamal El-Din A A Abuo-Rahma, Mohamed Abdel-Aziz, Eman A M Beshr, et al.
Bioorganic & Medicinal Chemistry|May 14, 2013
New nitric oxide donating 1,2,4-triazole/oxime hybrids: synthesis, investigation of anti-inflammatory, ulceroginic liability and antiproliferative activitiesMohamed Abdel-Aziz, Gamal El-Din A A Abuo-Rahma, Eman A M Beshr, et al.
BMC Chemistry|July 12, 2023
Indole-based FLT3 inhibitors and related scaffolds as potential therapeutic agents for acute myeloid leukemiaHend A A Ezelarab, Taha F S Ali, Samar H Abbas, et al.
International Journal of Molecular Sciences|May 14, 2022
Novel Inhibitor for Downstream Targeting of Transforming Growth Factor-β Signaling to Suppress Epithelial to Mesenchymal Transition and Cell MigrationTsugumasa Toma, Hiroshi Tateishi, Kensaku Kawakami, et al.
Molecular Diversity|February 15, 2023
New antiproliferative 3-substituted oxindoles inhibiting EGFR/VEGFR-2 and tubulin polymerizationHend A A Ezelarab, Taha F S Ali, Samar H Abbas, et al.
RSC Advances|July 22, 2022
Secondary metabolites of <i>Livistona decipiens</i> as potential inhibitors of SARS-CoV-2Seham S El-Hawary, Taha F S Ali, Sara O Abo El-Ela, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Zentralblatt Fur Mikrobiologie|January 1, 1986
Microbiological control of ticksF S Ali, A A Abdel-Moneim, T A el-Dahtory, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Biologically Active Benzimidazole Hybrids as Cancer Therapeutics: Recent AdvancesMohamed A S Badawy, Stefan Bräse, Taha F S Ali, et al.
Life Sciences|June 28, 2024
The protective role of two oxindole derivatives is mediated by modulating NLRP3/caspase-1 and PI3K/AKT pathways in a preclinical animal model of hepatic ischemia reperfusion injuryNardeen Eldafashi, Shaimaa Waaz, Taha F S Ali, et al.
Drug Development Research|May 26, 2026
Discovery of Novel 5-Substituted-4-Allyl-1,2,4-Triazoles as Potential Nonsteroidal Anti-Inflammatory Agents via Downregulation of iNOS ExpressionSamar H Abbas, Asmaa S A Hammad, Dina M M H El-Kossi, et al.
European Journal of Medicinal Chemistry|December 7, 2013
1,2,4-Triazole/oxime hybrids as new strategy for nitric oxide donors: Synthesis, anti-inflammatory, ulceroginicity and antiproliferative activitiesGamal El-Din A A Abuo-Rahma, Mohamed Abdel-Aziz, Eman A M Beshr, et al.
Bioorganic & Medicinal Chemistry|May 14, 2013
New nitric oxide donating 1,2,4-triazole/oxime hybrids: synthesis, investigation of anti-inflammatory, ulceroginic liability and antiproliferative activitiesMohamed Abdel-Aziz, Gamal El-Din A A Abuo-Rahma, Eman A M Beshr, et al.
BMC Chemistry|July 12, 2023
Indole-based FLT3 inhibitors and related scaffolds as potential therapeutic agents for acute myeloid leukemiaHend A A Ezelarab, Taha F S Ali, Samar H Abbas, et al.
International Journal of Molecular Sciences|May 14, 2022
Novel Inhibitor for Downstream Targeting of Transforming Growth Factor-β Signaling to Suppress Epithelial to Mesenchymal Transition and Cell MigrationTsugumasa Toma, Hiroshi Tateishi, Kensaku Kawakami, et al.
Molecular Diversity|February 15, 2023
New antiproliferative 3-substituted oxindoles inhibiting EGFR/VEGFR-2 and tubulin polymerizationHend A A Ezelarab, Taha F S Ali, Samar H Abbas, et al.
RSC Advances|July 22, 2022
Secondary metabolites of <i>Livistona decipiens</i> as potential inhibitors of SARS-CoV-2Seham S El-Hawary, Taha F S Ali, Sara O Abo El-Ela, et al.
Pageof 6